An immunotherapy survivor population: health-related quality of life and toxicity in patients with metastatic melanoma treated with immune checkpoint inhibitors

ConclusionsOur results show that metastatic melanoma survivors have potentially experienced significant ICI-related toxicity and experience significant impairments in specific HRQoL domains. Future service planning is required to meet this population ’s unique survivorship needs.
Source: Supportive Care in Cancer - Category: Cancer & Oncology Source Type: research